Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer
American Society of Clinical Oncology Educational Book · 2024
DOI: 10.1200/edbk_438598 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2024. Verfasst von Rachael A Safyan und 6 weiteren Autor:innen. Beteiligte Einrichtung: University of Washington School of Medicine, Department of Medicine, Division of Hematology-Oncology, Seattle, WA. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 123 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDA) is a challenging disease that presents at an advanced stage and results in many symptoms that negatively influence patients' quality of life and reduce their ability to receive effective treatment. Early implementation of expert multidisciplinary care with nutritional support, exercise, and palliative care for both early-stage and advanced disease promises to maintain or improve the patients' physical, social, and psychological well-being, decrease aggressive interventions at the end of life, and ultimately improve survival. Moreover, advances in treatment strategies in the neoadjuvant and metastatic setting combined with novel therapeutic agents targeting the key drivers of the disease are leading to improvements in the care of patients with pancreatic cancer. Here, we emphasize the multidisciplinary supportive and therapeutic care of patients with PDA, review current guidelines and new developments of neoadjuvant and perioperative treatments for localized disease, as well as the treatment standards and the evolving field of precision oncology and immunotherapies for advanced PDA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Washington School of Medicine, Department of Medicine, Division of Hematology-Oncology, Seattle, WA.
- Fred Hutchinson Cancer Center, Clinical Research Division, Seattle, WA.
- Dana-Farber Cancer Center, Department of Medical Oncology, Boston, MA.
- Harvard Medical School, Boston, MA.
- Erasmus MC Cancer Institute, Department of Surgery, Rotterdam, the Netherlands.
- Erasmus MC Cancer Institute, Department of Medical Oncology, Rotterdam, the Netherlands.
ORCID-Profile: E Gabriela Chiorean
Zitieren
APA
Safyan, R. A., Kim, E., Dekker, E., Homs, M., Aguirre, A. J., Koerkamp, B. G., & Chiorean, E. G. (2024). Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_438598
Vancouver
Safyan RA, Kim E, Dekker E, Homs M, Aguirre AJ, Koerkamp BG, et al. Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer. American Society of Clinical Oncology Educational Book. 2024. doi:10.1200/edbk_438598
BibTeX
@article{Safyan2024,
author = {Safyan, Rachael A and Kim, Eejung and Dekker, Emmelie and Homs, Marjolein and Aguirre, Andrew J and Koerkamp, Bas Groot and Chiorean, E Gabriela},
title = {Multidisciplinary Standards and Evolving Therapies for Patients With Pancreatic Cancer},
journal = {American Society of Clinical Oncology Educational Book},
year = {2024},
doi = {10.1200/edbk_438598}
}
EUVIMED